pneumonia

02/28/2012 - 12:01

The bacterium Mycoplasma pneumoniae, which causes atypical pneumonia, is helping scientists uncover how cells make the most of limited resources. By measuring all the proteins this bacterium produces, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and collaborators, have found that the secret is fine-tuning.

02/13/2012 - 13:47

North Carolina State University chemists have created a compound that makes existing antibiotics 16 times more effective against recently discovered antibiotic-resistant “superbugs.”

01/31/2012 - 09:57

An international research team may have found a way to block a second wave of death that can result from pneumonia treatment. Antibiotics are effective at killing pneumococcus – the cause of about 50 percent of pneumonias – but as it dies the bacterium releases potentially lethal toxins.

11/28/2011 - 14:15

Brigham and Women's Hospital (BWH) researchers have created a vaccine that is more potent than traditional vaccines available today. The glycoconjugate vaccine prototype is 100 times more effective than traditional glycoconjugate vaccines. A glycoconjugate vaccine is comprised of covalently bound carbohydrate and protein molecules, and is the standard design for many vaccines used to protect against common diseases such as pneumonia and meningitis. 

09/23/2011 - 11:44

Many of the people who died from the new strain of H1N1 influenza that broke out in 2009 were suffering from another infection as well: pneumonia. A new study to be published Tuesday, September 20 in the online journal mBio reveals how the two infections, pandemic influenza and pneumonia, interact to make to make a lethal combination.

10/23/2010 - 23:00

Develop a therapy to treat Fanconi anemia, a fatal genetic blood disease. The researchers will investigate new ways to create induced pluripotent stem (iPS) cells from a patient's skin or other tissue